Assessment of Usefulness of Randomized Control Trials in Child Health Research Published in 2007 and 2017

Bartosh Kaminski1, Alex Aregbesola1, Clara Tam2

  • 1Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada; Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, Canada.

PubMed

Insights

Clinical usefulness in pediatric randomized controlled trials (RCTs) improved significantly over a decade. However, areas like patient centeredness and data availability require further enhancement to reduce research waste.

Area of Science:

  • Pediatric Research
  • Clinical Trials
  • Health Outcomes

Background:

  • Assessing the clinical usefulness of pediatric research is crucial for optimizing healthcare interventions.
  • Randomized controlled trials (RCTs) are a cornerstone of evidence-based medicine, but their real-world applicability can vary.
  • A decade-long analysis is needed to understand trends in the clinical utility of child health research.

Approach:

  • A comparative analysis of pediatric RCTs published in 2007 and 2017 was conducted.
  • A standardized tool evaluating 11 criteria of clinical usefulness was applied to 600 RCTs (300 per year).
  • Statistical methods were employed to assess changes in clinical usefulness over the 10-year period.

Key Points:

  • The mean clinical usefulness score for pediatric RCTs increased from 6.07 in 2007 to 9.20 in 2017.
  • Improvements were noted in reporting of context placement, funding, and conflict of interest statements.
  • Patient centeredness, value for money, and raw data availability remain underreported areas.

Conclusions:

  • Pediatric research demonstrates enhanced clinical usefulness over a 10-year span.
  • Despite improvements, significant opportunities exist to further increase the clinical utility of pediatric studies.
  • Addressing current gaps can help minimize research waste and maximize the impact of child health research.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
129
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
225
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.0K